// App-Quantinova.ai

Tu1783 : SOCS-3 Inhibition Prevents Impairment of Vagal Afferent Excitability and Response to Satiety Mediators Induced by Obese Mouse Serum

Researchers

Presenter

  • Michael Beyak

Principal Investigators

  • N/A

Medical Centers

  • Gastrointestinal Diseases Research Unit, Dept of Medicine, Queens University, Kingston, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Obesity

Biomarkers

  • Serotonin

  • Suppressor Of Cytokine Signaling 3

Drug/Treatment

  • Zoledronic acid

  • Mofezolac

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved